| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Cell Biology (Cancer Research) [C. B., M. F. R., J. T.] and Department of Internal Medicine (Cancer Research) [M. R. M., S. S.], University of Essen Medical School, D-45122 Essen, Germany
Recent evidence has linked cellular DNA repair capacity to the chemosensitivity of cancer cells to alkylating agents. Using single-cell gel electrophoresis ("comet assay"), we have analyzed the induction and differential processing of DNA damage in human lymphocytes derived from healthy donors and from patients with chronic lymphatic leukemia (CLL) after exposure to N-ethyl-N-nitrosourea in vitro.
The extent of comet formation in lymphocytes after N-ethyl-N-nitrosourea exposure appears to depend predominantly on the processing of DNA repair intermediates, because strand breaks in plasmid DNA were not induced by ethylation before the addition of nuclear proteins. Although the initial level of a specific alkylation product (O6-ethylguanine) in nuclear DNA was uniform, different dose-response curves were obtained for the comet size in individual cell samples immediately after exposure, with small intercellular variation. The individual kinetics of DNA repair varied significantly between specimens derived from both healthy individuals and CLL patients; for the DNA repair half-time (t1/2), large difference was found.
Pretreatment of cells with methoxyamine as a DNA repair modifier blocking the base excision repair pathway revealed a quite similar extent of base excision repair-independent DNA incision in almost all normal lymphocyte samples. In contrast, this portion varied relatively and absolutely to a great extent among individual samples of CLL lymphocytes, suggesting a loss of stringent control of DNA repair processes in these cells. The comet assay can thus be used to gain information about inter-individual variation in the efficiency of different DNA repair processes in small samples of normal cells and their malignant counterparts.
1 This work was supported by the Dr. Mildred Scheel Stiftung für Krebsforschung.
2 To whom requests for reprints should be addressed, at Institute of Cell Biology (Cancer Research), University of Essen Medical School, Virchowstrasse 173, D-45122 Essen, Germany. Phone: 49 201 723 3385; Fax: 49 201 723 5904.
Received 8/19/96. Accepted 12/20/96.
This article has been cited by other articles:
![]() |
M. A. Moufarij, D. Sampath, M. J. Keating, and W. Plunkett Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal Blood, December 15, 2006; 108(13): 4187 - 4193. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. U. Bracker, B. Giebel, J. Spanholtz, U. R. Sorg, L. Klein-Hitpass, T. Moritz, and J. Thomale Stringent Regulation of DNA Repair During Human Hematopoietic Differentiation: A Gene Expression and Functional Analysis Stem Cells, March 1, 2006; 24(3): 722 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gale, C. P. Romero, G. B. Tafoya, and J. Conia Application of Optical Trapping for Cells Grown on Plates: Optimization of PCR and Fidelity of DNA Sequencing of p53 Gene from a Single Cell Clin. Chem., March 1, 2003; 49(3): 415 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Buschfort-Papewalis, T. Moritz, B. Liedert, and J. Thomale Down-regulation of DNA repair in human CD34+ progenitor cells corresponds to increased drug sensitivity and apoptotic response Blood, July 18, 2002; 100(3): 845 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamauchi, B. J. Nowak, M. J. Keating, and W. Plunkett DNA Repair Initiated in Chronic Lymphocytic Leukemia Lymphocytes by 4-Hydroperoxycyclophosphamide Is Inhibited by Fludarabine and Clofarabine Clin. Cancer Res., November 1, 2001; 7(11): 3580 - 3589. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, P. Taverna, C. M. Whitacre, S. Chatterjee, and S. L. Gerson Pharmacologic Disruption of Base Excision Repair Sensitizes Mismatch Repair-deficient and -proficient Colon Cancer Cells to Methylating Agents Clin. Cancer Res., October 1, 1999; 5(10): 2908 - 2917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Engelbergs, J. Thomale, A. Galhoff, and M. F. Rajewsky Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea PNAS, February 17, 1998; 95(4): 1635 - 1640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |